| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antibiotic prescribing in general practice during COVID-19 and beyond
|
Bryant, Olivia K
|
|
|
23 |
1 |
p. 32-33
|
article
|
| 2 |
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
|
Tripura, Rupam
|
|
|
23 |
1 |
p. 81-90
|
article
|
| 3 |
Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections
|
Aaby, Peter
|
|
|
23 |
1 |
p. e34-e42
|
article
|
| 4 |
Buddha Basnyat—tackling typhoid and other infections in Nepal
|
Kirby, Tony
|
|
|
23 |
1 |
p. 42
|
article
|
| 5 |
Bulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed
|
Ito, Takanori
|
|
|
23 |
1 |
p. 14-16
|
article
|
| 6 |
Climate change and the increased burden of dengue fever in Pakistan
|
Abid, Muhammad Abbas
|
|
|
23 |
1 |
p. 17-18
|
article
|
| 7 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye
|
|
|
23 |
1 |
p. 19-21
|
article
|
| 8 |
Correction to Lancet Infect Dis 2022; published online Aug 29. https://doi.org/10.1016/S1473-3099(22)00499-6
|
|
|
|
23 |
1 |
p. e1
|
article
|
| 9 |
Correction to Lancet Infect Dis 2022; published online Nov 9. https://doi.org/10.1016/S1473-3099(22)00584-9
|
|
|
|
23 |
1 |
p. e1
|
article
|
| 10 |
Correction to Lancet Infect Dis 2022; published online Oct 19. https://doi.org/10.1016/S1473-3099(22)00644-2
|
|
|
|
23 |
1 |
p. e1
|
article
|
| 11 |
Correction to Lancet Infect Dis 2022; published online Oct 4. https://doi.org/10.1016/S1473-3099(22)00508-4
|
|
|
|
23 |
1 |
p. e1
|
article
|
| 12 |
Correction to Lancet Infect Dis 2022; published online Sept 13. https://doi.org/10.1016/S1473-3099(22)00506-0
|
|
|
|
23 |
1 |
p. e1
|
article
|
| 13 |
COVID-19 vaccination protects children and adolescents
|
Irving, Stephanie A
|
|
|
23 |
1 |
p. 5-6
|
article
|
| 14 |
Decline of RSV-specific antibodies during the COVID-19 pandemic
|
den Hartog, Gerco
|
|
|
23 |
1 |
p. 23-25
|
article
|
| 15 |
Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study
|
Nsio, Justus
|
|
|
23 |
1 |
p. 91-102
|
article
|
| 16 |
Dilip Mahalanabis
|
Bagcchi, Sanjeet
|
|
|
23 |
1 |
p. 40
|
article
|
| 17 |
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
|
Hoffmann, Markus
|
|
|
23 |
1 |
p. 25-28
|
article
|
| 18 |
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study
|
Bardsley, Megan
|
|
|
23 |
1 |
p. 56-66
|
article
|
| 19 |
Estimating hospital admissions due to respiratory syncytial virus in children
|
Hardelid, Pia
|
|
|
23 |
1 |
p. 33
|
article
|
| 20 |
Estimating hospital admissions due to respiratory syncytial virus in children – Authors' reply
|
Bardsley, Megan
|
|
|
23 |
1 |
p. 33-34
|
article
|
| 21 |
Harm reduction and rights-based approaches to reduce monkeypox transmission among sex workers
|
Strathdee, Steffanie A
|
|
|
23 |
1 |
p. e43-e46
|
article
|
| 22 |
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
|
Perico, Norberto
|
|
|
23 |
1 |
p. e22-e33
|
article
|
| 23 |
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
|
Uraki, Ryuta
|
|
|
23 |
1 |
p. 30-32
|
article
|
| 24 |
Hybrid immunity and strategies for COVID-19 vaccination
|
Hui, David S
|
|
|
23 |
1 |
p. 2-3
|
article
|
| 25 |
IDWeek 2022
|
Kazi, Farooq
|
|
|
23 |
1 |
p. 36
|
article
|
| 26 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
1 |
p. 38
|
article
|
| 27 |
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study
|
Amir, Ofra
|
|
|
23 |
1 |
p. 67-73
|
article
|
| 28 |
Jacqueline Deen—taking the fight to paediatric diseases globally
|
Kirby, Tony
|
|
|
23 |
1 |
p. 41
|
article
|
| 29 |
Monkeypox virus in human body sites and fluids: evidence for transmission
|
Colavita, Francesca
|
|
|
23 |
1 |
p. 6-8
|
article
|
| 30 |
Nepal faces an outbreak of dengue
|
Bagcchi, Sanjeet
|
|
|
23 |
1 |
p. 35
|
article
|
| 31 |
Ocular toxoplasmosis in a patient with acquired immunodeficiency syndrome
|
Chang, Chun-Hsiang
|
|
|
23 |
1 |
p. 130
|
article
|
| 32 |
Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
|
Jiang, Xiao-Lin
|
|
|
23 |
1 |
p. 28-30
|
article
|
| 33 |
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
|
Arora, Prerna
|
|
|
23 |
1 |
p. 22-23
|
article
|
| 34 |
Our new cover artist for 2023
|
De Ambrogi, Marco
|
|
|
23 |
1 |
p. 21
|
article
|
| 35 |
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
|
Carazo, Sara
|
|
|
23 |
1 |
p. 45-55
|
article
|
| 36 |
Quantifying the RSV immunity debt following COVID-19: a public health matter
|
Billard, Marie-Noëlle
|
|
|
23 |
1 |
p. 3-5
|
article
|
| 37 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
1 |
p. 39
|
article
|
| 38 |
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
|
Mazur, Natalie I
|
|
|
23 |
1 |
p. e2-e21
|
article
|
| 39 |
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
|
Wedemeyer, Heiner
|
|
|
23 |
1 |
p. 117-129
|
article
|
| 40 |
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies
|
Marshall, Helen S
|
|
|
23 |
1 |
p. 103-116
|
article
|
| 41 |
Serogroup B meningococcal vaccines from the public health perspective
|
Mueller, Judith E
|
|
|
23 |
1 |
p. 13-14
|
article
|
| 42 |
Struggling with a new dengue epidemic in Nepal
|
Pandey, Basu Dev
|
|
|
23 |
1 |
p. 16-17
|
article
|
| 43 |
The positive outcomes of the Black Death
|
Burki, Talha
|
|
|
23 |
1 |
p. 44
|
article
|
| 44 |
The role of chemoprophylaxis in eliminating forest malaria and preventing simian malaria in humans
|
Chen, Ingrid
|
|
|
23 |
1 |
p. 8-10
|
article
|
| 45 |
The sound of waves: tracking the pandemic
|
Nguyen, Tri-Long
|
|
|
23 |
1 |
p. 43
|
article
|
| 46 |
Triage of patients with Ebola virus disease
|
Lang, Hans-Joerg
|
|
|
23 |
1 |
p. 10-12
|
article
|
| 47 |
Twin threats: climate change and zoonoses
|
The Lancet Infectious Diseases,
|
|
|
23 |
1 |
p. 1
|
article
|
| 48 |
Viral loads in clinical samples of men with monkeypox virus infection: a French case series
|
Palich, Romain
|
|
|
23 |
1 |
p. 74-80
|
article
|
| 49 |
WHO antimalarial strategy for Africa
|
Burki, Talha
|
|
|
23 |
1 |
p. 37-38
|
article
|
Journal description